Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:selegiline
|
| gptkbp:approvedBy |
gptkb:FDA
2006 |
| gptkbp:ATCCode |
N06AF09
|
| gptkbp:brand |
gptkb:selegiline
|
| gptkbp:contraindication |
gptkb:pheochromocytoma
concomitant use with SSRIs concomitant use with tricyclic antidepressants |
| gptkbp:drugClass |
monoamine oxidase inhibitor
|
| gptkbp:form |
musical composition
|
| https://www.w3.org/2000/01/rdf-schema#label |
Emsam
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
Mylan Pharmaceuticals
|
| gptkbp:mechanismOfAction |
MAO-B inhibition
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
transdermal patch
|
| gptkbp:sideEffect |
headache
insomnia skin irritation |
| gptkbp:usedFor |
gptkb:major_depressive_disorder
|
| gptkbp:bfsParent |
gptkb:Selegiline
gptkb:selegiline |
| gptkbp:bfsLayer |
7
|